Application Notes: Pharmaceuticals

Antiretrovirals have come back to the forefront of separation science at this moment in time, as they have found use in the fight against SARS-CoV-2.

This application note demonstrates robust and sensitive quantitation of 10 nitrosamines, and the use of the LC–SRM–MS to quantify nitrosamine impurities in metformin.

This application note demonstrates fast, highly sensitive quantitation of nine nitrosamines, and the use of the LC–MS method to measure nitrosamine.

The pharma industry is embracing the challenge of sustainability by using greener solvents. A GC–MS method for analyzing 32 green solvents is presented.

Using fast, efficient HALO® Fused-Core® technology columns and manipulating selectivity quickly develops methods for fast, high-efficiency LC and LC–MS separations.

This application demonstrates HALO® Biphenyl is an ideal choice for high throughput analysis of drug panels, in which isobaric species separation is needed.

The separation of non-steroidal anti-inflammatory drugs 60% less time, with better resolution than a typical HPLC column packed with fully porous particles, is demonstrated.

The 30 mg Microlute® CP Strong Cation Exchange (SCX) 96 well plate compares performance in recoveries and reproducibility against five competitor loose-filled 30 mg SCX products.

This application demonstrates the efficiency, throughput, and reliability of a dual-injection system for finished pharmaceutical products and in-process APIs.

This white paper demonstrates a vendor’s perspective on recent trends in regulations and the potential future direction for the industry.

This white paper demonstrates a vendor’s perspective on recent trends in regulations and the potential future direction for the industry.

Modified nucleosides, either natural or synthetic, often provide RNA with distinctive properties useful in diagnostics or therapeutics.  

Learn how impurity-monitoring software can improve your understanding of your process route and help you track fate and purge.  

FFF-MALS-DLS provides the detailed characterization of nano-pharmaceuticals that is essential for development and regulatory filing.

This white paper provides a vendor’s perspective on recent trends in regulations and the potential future direction for the industry referred to as “Pharma 4.0”.

Using Empower CDS and NuGenesis LMS to develop an archive strategy that reduces backup and recovery times and removes manual intervention is demonstrated.

Companies can seek outside help for backup and restore, disaster recovery, and system administration, but responsibility for regulated data remains with the company.

VITAQUEST, a contract manufacturer of dietary supplements, used NuGenesis LMS to automate its workflows, improve lab efficiency, and reduce the risk for data errors.

This study shows how coupling Waters’ Empower CDS with cloud technology allowed a pharmaceutical company to streamline its global operations and connect each of its labs.

This white paper explains the 21 CFR Part 11 and EU EudraLex Annex 11 compliance readiness of Waters Empower Software for the regulated scientific laboratory.

This case study demonstrates the advantages of pairing Empower CDS with NuGenesis LMS to improve the availability of your CDS data and maximize its effectiveness.

A&M Stabtest, an independent CRO in the pharmaceutical industry, reduced time-consuming and error-prone manual steps in the chromatographic testing process.

An investment in Waters NuGenesis LMS helped a global pharmaceutical CDMO meet demands for data integrity regulatory compliance and laboratory management needs.

This study demonstrates Waters ACQUITY UPLC with PDA/QDa technology and Empower Software were integral to successful method lifecycle management at Hovione, a global CDMO.